The paracrine action of bFGF, in stimulating local tumour‐associated angiogenesis via FGFR1, may be accompanied by rising levels of the growth factor within the sera of affected patients, the measurement of which has been used as a prognostic biomarker (Akl et al., 2016). This evidence concerns the gene FGFR1 and neoplasm.